BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

CapitalBio Technology raises over $113M in pre-IPO round  CapitalBio Corp. subsidiary CapitalBio Technology Co Ltd. raised over RMB800 million ($113 million) in a pre-IPO financing round last week led by Guangdong Boyi Design Institute Co....
BioCentury | Mar 30, 2020
Politics, Policy & Law

When COVID-19’s spread slows, reopening the nation will depend on diagnostics

Emerging from limitations imposed to prevent the spread of COVID-19 will depend on widely deploying rapid point-of-care diagnostics and complementary serological tests, according to a report from the American Enterprise Institute co-authored by former FDA...
BC Extra | Nov 7, 2019
Clinical News

ALS group launches trial of digital app to track progression

A new mobile app could help patients, physicians and drug developers track amyotrophic lateral sclerosis disease progression to better understand whether an investigational therapy is working and learn more about the natural history of the...
BC Extra | Nov 5, 2019
Company News

Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition

Santhera Pharmaceuticals Holding AG ( SIX:SANN) said Dario Eklund will succeed Thomas Meier as CEO, effective Dec. 1. Meier will remain on the rare neuromuscular and pulmonary disease company's board and chair its scientific committee. Eklund...
BC Extra | Oct 7, 2019
Company News

Gilead fills CMO spot with Genentech exec Parsey

Gilead hired Merdad Parsey as CMO, filling a position that has been vacant for over a year at a company that has seen several high level departures since Chairman and CEO Daniel O'Day took the...
BC Extra | Sep 25, 2019
Company News

Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson

FDA approves Bavarian Nordic’s smallpox/monkeypox vaccine  FDA approved Jynneos MVA-BN from Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) to prevent smallpox and monkeypox, making the vaccine the only approved non-replicating smallpox vaccine in the U.S. and the...
BC Extra | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

Innate proposes U.S. listing  Innate Pharma S.A. (Euronext:IPH) filed to raise up to $100 million total across a NASDAQ listing and a European private placement. The antibody company markets CD22-targeted immunotoxin Lumoxiti moxetumomab in the...
BC Extra | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

Former FDA Commissioner Scott Gottlieb has joined the board of real-world evidence company Aetion Inc. Gottlieb was a champion of integrating real-world evidence into product development during his tenure as commissioner, and Aetion was one...
BC Innovations | Aug 2, 2019
Distillery Techniques

Genetic biomarkers for anorexia nervosa

TECHNIQUES CATEGORY: Biomarkers TECHNOLOGY: SNPs; gene profiling SNPs in eight genomic regions could predict risk of anorexia nervosa. The loci were identified in a meta-analysis of 33 genome-wide association studies (GWAS) covering 16,992 anorexic patients...
BC Extra | Jul 17, 2019
Company News

Gilead CSO McHutchison, two others, out as O’Day reshapes his team

With the departures of CSO John McHutchison, Chief Patient Officer Gregg Alton and EVP of Human Resources Katie Watson announced Wednesday, Daniel O'Day will be left with less than half of the 10-person senior management...
Items per page:
1 - 10 of 555
BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

CapitalBio Technology raises over $113M in pre-IPO round  CapitalBio Corp. subsidiary CapitalBio Technology Co Ltd. raised over RMB800 million ($113 million) in a pre-IPO financing round last week led by Guangdong Boyi Design Institute Co....
BioCentury | Mar 30, 2020
Politics, Policy & Law

When COVID-19’s spread slows, reopening the nation will depend on diagnostics

Emerging from limitations imposed to prevent the spread of COVID-19 will depend on widely deploying rapid point-of-care diagnostics and complementary serological tests, according to a report from the American Enterprise Institute co-authored by former FDA...
BC Extra | Nov 7, 2019
Clinical News

ALS group launches trial of digital app to track progression

A new mobile app could help patients, physicians and drug developers track amyotrophic lateral sclerosis disease progression to better understand whether an investigational therapy is working and learn more about the natural history of the...
BC Extra | Nov 5, 2019
Company News

Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition

Santhera Pharmaceuticals Holding AG ( SIX:SANN) said Dario Eklund will succeed Thomas Meier as CEO, effective Dec. 1. Meier will remain on the rare neuromuscular and pulmonary disease company's board and chair its scientific committee. Eklund...
BC Extra | Oct 7, 2019
Company News

Gilead fills CMO spot with Genentech exec Parsey

Gilead hired Merdad Parsey as CMO, filling a position that has been vacant for over a year at a company that has seen several high level departures since Chairman and CEO Daniel O'Day took the...
BC Extra | Sep 25, 2019
Company News

Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson

FDA approves Bavarian Nordic’s smallpox/monkeypox vaccine  FDA approved Jynneos MVA-BN from Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) to prevent smallpox and monkeypox, making the vaccine the only approved non-replicating smallpox vaccine in the U.S. and the...
BC Extra | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

Innate proposes U.S. listing  Innate Pharma S.A. (Euronext:IPH) filed to raise up to $100 million total across a NASDAQ listing and a European private placement. The antibody company markets CD22-targeted immunotoxin Lumoxiti moxetumomab in the...
BC Extra | Sep 17, 2019
Company News

Management tracks: Gottlieb joins Aetion board; plus Alexion, Encoded, PhRMA, Rgenix, Lyra, twoXAR and Innoplexus

Former FDA Commissioner Scott Gottlieb has joined the board of real-world evidence company Aetion Inc. Gottlieb was a champion of integrating real-world evidence into product development during his tenure as commissioner, and Aetion was one...
BC Innovations | Aug 2, 2019
Distillery Techniques

Genetic biomarkers for anorexia nervosa

TECHNIQUES CATEGORY: Biomarkers TECHNOLOGY: SNPs; gene profiling SNPs in eight genomic regions could predict risk of anorexia nervosa. The loci were identified in a meta-analysis of 33 genome-wide association studies (GWAS) covering 16,992 anorexic patients...
BC Extra | Jul 17, 2019
Company News

Gilead CSO McHutchison, two others, out as O’Day reshapes his team

With the departures of CSO John McHutchison, Chief Patient Officer Gregg Alton and EVP of Human Resources Katie Watson announced Wednesday, Daniel O'Day will be left with less than half of the 10-person senior management...
Items per page:
1 - 10 of 555